Skip to content

MEDAIRE TURNS 40!

Celebrating a legacy of innovation and industry firsts from developing bespoke medical kits to founding the first global response centre for aviation. Our commitment to pioneering solutions continues as we look ahead, ensuring excellence for every journey.

iStock-2217097274

Safety Advisory: Increased Needle Risk in Guest Waste Onboard Yacht

Overview

Crew are encountering more used needles in guest waste due to rising use of injectable GLP‑1 weight‑loss and diabetes medications. Improperly discarded injection pens increase the risk of accidental needlestick injuries. Yacht crew should follow a defined response protocol when an exposure occurs.

Quick Answer

Yacht crew may need to apply enhanced waste‑handling precautions to mitigate against the risk of sharps injuries, associated with medical injections.

Safety Advisory: Increased Needle Risk in Guest Waste and Crew Response to Needlestick Injuries

1. Why Needle Exposure Risk Is Increasing

The use of injectable GLP‑1 medications—such as Ozempic, Wegovy, and Mounjaro—has increased significantly. Many guests now travel with prefilled injection pens for weight loss or Type 2 diabetes management. These pens are often small, medical‑looking devices that do not resemble traditional needles, making them easy to miss in general waste.

Common disposal issues include:

  • Pens discarded in bathroom bins
  • Pens hidden in tissues or packaging
  • Pens mixed with general cabin waste
  • Uncapped devices placed in soft trash bags

The global rise in Type 2 diabetes also contributes to increased onboard injectable medication use. As a result, crews should expect more sharps exposure risks during cabin servicing and waste collection.

2. How Crew Can Prevent Needlestick Injuries

Providing preventative systems reduces sharps exposure for flight and yacht crews. MedAire recommends placing discreet sharps containers in guest cabins to encourage safe disposal. However, sharps may still end up in general waste, so operational precautions remain essential.

Risk‑reduction practices:

  • Treat all guest waste as potentially hazardous.
  • Do not compress bags with your hands.
  • Use puncture‑resistant gloves when appropriate.
  • Visually inspect waste before handling.
  • Place any discovered sharp objects into a rigid sharps container.
  • Report any known or suspected sharps immediately to the safety lead.

Any found needle should be handled as a biohazardous sharp.

3. What Crew Should Do Immediately After a Needlestick Injury

Follow these steps promptly and calmly if a crew member is injured:

Step 1

Wash the area

  • Wash the site with soap and water.
  • Do not scrub or use harsh chemicals.

Step 2

Encourage mild bleeding

  • Gently massage around the wound to promote brief, light bleeding.
  • Do not suck the wound.

Step 3

Gather essential information

If appropriate and discreet:

  • Determine whether the individual who used the injection device (if identifiable)
    • Has ever been tested for HIV, Hepatitis B, or Hepatitis C
    • Has Hepatitis B vaccination
    • Has any known blood‑borne infection history

Also document:

  • The injured crew member’s vaccination status (especially Hepatitis B)
  • Details about the needle’s appearance, where it was found, and how the injury occurred

Step 4

Contact MedAire / MedLink

Provide all collected information so medical specialists can conduct an accurate exposure‑risk assessment and recommend next steps.

4. Medical Management After Exposure

A medical professional will assess risk by reviewing:

  • Needle type
  • Whether the source patient is known
  • Medical history of the source and crew member
  • Severity and nature of the exposure

Possible management includes:

A. Blood tests

  • Baseline testing shortly after the injury
  • Follow‑up tests at 6, 12, and 24 weeks
  • Monitoring for HIV, Hepatitis B, and Hepatitis C seroconversion

B. HIV Post‑Exposure Prophylaxis (PEP)

  • Recommended only when a credible HIV exposure risk exists
  • Must begin within 72 hours
  • 28‑day medication course

C. Hepatitis B management

  • Vaccination for unvaccinated crew
  • Possible addition of Hepatitis B Immunoglobulin depending on risk

D. Hepatitis C monitoring

  • No immediate medication or vaccine
  • Serial blood tests and symptom monitoring required

5. Key Takeaways for Aviation and Maritime Crew

  • The presence of used needles in guest waste is increasing due to widespread GLP‑1 and diabetes‑related injectable use.
  • Add sharps containers to guest cabins to support safe, discreet disposal.
  • Treat all waste as potentially hazardous and follow strict waste‑handling procedures.
  • If a needlestick injury occurs, apply the immediate steps outlined above.
  • Provide complete exposure information when contacting MedAire or MedLink.
  • Continued medical monitoring may be necessary depending on risk.

INDUSTRY RELATED DATA